StockNews.com began coverage on shares of Myovant Sciences (NYSE:MYOV – Get Rating) in a report published on Monday morning. The firm issued a hold rating on the stock. Myovant Sciences Stock Performance NYSE:MYOV opened at $26.98 on Monday. Myovant Sciences has a one year low of $7.67 and a one year high of $27.06. The […]
StockNews.com initiated coverage on shares of Myovant Sciences (NYSE:MYOV – Get Rating) in a research note released on Sunday. The brokerage issued a hold rating on the stock. Myovant Sciences Trading Down 0.0 % Shares of Myovant Sciences stock opened at $26.98 on Friday. Myovant Sciences has a 12-month low of $7.67 and a 12-month […]
Creative Planning purchased a new stake in shares of Myovant Sciences Ltd. (NYSE:MYOV – Get Rating) during the third quarter, Holdings Channel.com reports. The fund purchased 27,245 shares of the company’s stock, valued at approximately $489,000. A number of other large investors also recently made changes to their positions in the company. Arizona State Retirement […]
Brokerages expect Myovant Sciences Ltd. (NYSE:MYOV – Get Rating) to post earnings per share of ($0.21) for the current fiscal quarter, Zacks reports. Two analysts have issued estimates for Myovant Sciences’ earnings. The highest EPS estimate is ($0.08) and the lowest is ($0.42). Myovant Sciences posted earnings per share of ($0.67) during the same quarter […]
Brokerages expect that Myovant Sciences Ltd. (NYSE:MYOV – Get Rating) will announce sales of $60.06 million for the current fiscal quarter, according to Zacks. Two analysts have provided estimates for Myovant Sciences’ earnings. The lowest sales estimate is $55.50 million and the highest is $64.62 million. Myovant Sciences reported sales of $24.61 million in the […]